시장보고서
상품코드
1448481

재생의료 시장 : 동향, 전망 및 경쟁 분석

Regenerative Medicine Market: Trends, Forecast and Competitive Analysis

발행일: | 리서치사: Lucintel | 페이지 정보: 영문 150 - page report | 배송안내 : 3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

재생의료 시장 동향 및 전망

세계 재생의료 시장은 2030년까지 102억 달러에 달할 것으로 추정되며, 2024-2030년간 연평균 3.0%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 개인 맞춤형 의료에 대한 사람들의 선호도 증가, 정부 및 민간 기관의 연구 개발 활동에 대한 투자 증가, 줄기세포 치료의 기술 발전입니다. 세계 재생의료 시장의 미래는 근골격계 질환, 상처 치료, 종양학, 안과 질환, 당뇨병 분야에서 유망한 기회가 있을 것으로 예상됩니다.

재생의료 시장의 새로운 동향

산업 역학에 직접적인 영향을 미치는 새로운 트렌드로는 줄기세포 기술의 채택 증가와 조직공학 및 재생의료 분야에서 3D 바이오프린팅 기술의 활용 증가를 들 수 있습니다.

이 시장에서 세포 기반 면역 및 세포 치료는 재생의료의 가장 큰 제품이며, 근골격계 질환은 가장 큰 응용 분야입니다. 재생의료 시장의 다양한 부문의 성장세는 다음과 같습니다.

이번 조사에서는 세계 재생의료 시장에 대한 소재별, 제품별, 용도별, 유통채널별, 지역별 동향과 전망을 다음과 같이 정리하였습니다.

재료별(2018-2030년 금액(백만 달러) 출하량 분석) :

  • 합성
    • 비계 재료
    • 인공혈관 이식재
    • 하이드로겔 재료
  • 생물 유래 재료
    • 콜라겐
    • 이종 재료
  • 유전자 변형 물질
    • 데옥시리보 핵산 감염 벡터
    • 유전자 조작 세포
    • 3차원 폴리머 기술
    • 형질 전환
    • 섬유아세포
    • 신경줄기세포
    • 유전자 활성화 매트릭스
  • 의약품
    • 저분자 의약품
    • 생물학적 제제

제품별(2018-2030년 금액(백만 달러) 출하량 분석) :

  • 세포 기반 면역치료 및 세포 치료 제품
  • 조직공학 제품
  • 저분자 및 생물학적 제제
  • 유전자 치료 제품

용도별(2018-2030년 출하액(백만 달러) 분석) : 근골격계 질환

  • 근골격계 질환
  • 상처 치료
  • 종양학
  • 안질환
  • 당뇨병
  • 기타

유통채널별(2018-2030년 금액(백만 달러) 출하량 분석)

  • 병원
  • 클리닉
  • 기타

지역별(2018-2030년 출하액(백만 달러) 분석) : 북미

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
  • 아시아태평양
    • 중국
    • 인도
    • 일본
  • 기타
    • 브라질

재생의료 시장 인사이트

  • Lucintel은 세포치료제 관련 R&D 활동에 대한 정부 지원 증가와 재생의료 승인 간소화를 위한 FDA의 Cures Act 제정으로 인해 세포 기반 면역학 및 세포치료제가 예측 기간 동안 가장 큰 부문을 차지할 것으로 예상하고 있습니다.
  • 이 시장에서 근골격계 질환은 정형외과 질환 증가와 노인 인구 증가로 인해 예측 기간 동안 가장 큰 응용 분야로 남을 것으로 예상됩니다.
  • 북미는 첨단 기술의 존재와 새로운 치료법 개발에 참여하는 연구 기관이 많기 때문에 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 예상됩니다.

자주 묻는 질문

Q1. 시장 규모 :

답변: 세계 재생의료 시장은 2030년까지 102억 달러에 달할 것으로 예상되는데, 이 시장 규모에 대해 말씀해 주십시오.

Q2. 시장 성장 예측은 다음과 같습니다.

답변: 재생의료 시장은 2024-2030년까지 연평균 3.0%의 성장률을 보일 것으로 예상됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 다음과 같습니다.

A1. 이 시장의 주요 촉진요인은 개인 맞춤형 의료에 대한 사람들의 선호도 증가, 정부 및 민간 기관의 연구개발 활동에 대한 투자 증가, 줄기세포 치료의 기술 발전입니다.

Q4. 재생의료의 주요 최종 용도는 무엇인가?

답변: 병원 및 클리닉이 재생의료의 주요 최종 용도입니다.

Q5. 재생의료 시장의 새로운 동향은?

답변: 산업 역학에 직접적인 영향을 미치는 새로운 트렌드로는 줄기세포 기술의 채택 증가와 조직공학 및 재생의료 분야에서 3D 바이오프린팅 기술의 활용 증가를 들 수 있습니다.

Q6. 주요 재생의료 기업은?

답변: 주요 재생의료 기업은 다음과 같습니다.

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Q7. 향후 재생의료 원료 부문에서 가장 성장할 분야는?

A4.Lucintel은 세포치료제 관련 R&D 활동에 대한 정부 지원 증가와 재생의료 승인을 간소화하기 위한 FDA의 Cures Act 제정으로 인해 세포 기반 면역 및 세포치료제가 예측 기간 동안 가장 큰 부문을 차지할 것으로 예상하고 있습니다.

Q8: 향후 5년간 재생의료 시장에서 가장 큰 시장이 될 지역은?

답변: 향후 5년 동안에도 북미가 가장 큽니다.

Q9. 보고서 사용자 정의가 가능합니까?

답변 : 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 명시하고 있습니다.

목차

제2장 시장 배경과 분류

  • 서론, 배경, 분류
  • 공급망
  • 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

  • 거시경제 동향과 예측
  • 세계의 재생의료 시장 동향과 예측
  • 재료별 세계의 재생의료 시장
    • 합성
      • 스캐폴드
      • 인공 혈관 재료
      • 하이드로겔 재료
    • 생물 유래 재료
      • 콜라겐
      • 이종 재료
    • 유전자 변형 물질
      • 데옥시리보 핵산 감염 벡터
      • 유전자 조작 세포
      • 3차원 폴리머 기술
      • 형질 전환
      • 섬유아세포
      • 신경줄기세포
      • 유전자 활성화 매트릭스
    • 의약품
      • 저분자
      • 생물제제
  • 제품별 세계의 재생의료 시장
    • 세포 기반 면역치료 및 세포치료 제품
    • 조직공학적으로 가공된 제품
    • 저분자 및 생물제제
    • 유전자 치료 제품
  • 용도별 세계의 재생의료 시장
    • 근골격계 질환
    • 창상 관리
    • 종양학
    • 안질환
    • 당뇨병
    • 기타
  • 유통 채널별 세계의 재생의료 시장
    • 병원
    • 클리닉
    • 기타

제4장 지역별 시장 동향과 예측 분석

  • 지역별 세계의 재생의료 시장
  • 북미의 재생의료 시장
  • 유럽의 재생의료 시장
  • 아시아태평양의 재생의료 시장
  • 기타 지역의 재생의료 시장

제5장 경쟁 분석

  • 시장 점유율 분석
  • 제품 포트폴리오 분석
  • 운영상 통합
  • 지역적 범위
  • Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

  • 성장 기회 분석
    • 재료별 세계의 재생의료 시장 성장 기회
    • 제품별 세계의 재생의료 시장 성장 기회
    • 용도별 세계의 재생의료 시장 성장 기회
    • 유통 채널별 세계의 재생의료 시장 성장 기회
    • 지역별 세계의 재생의료 시장 성장 기회
  • 세계 재생의료 시장의 새로운 동향
  • 전략적 분석
    • 신제품 개발
    • 세계의 재생의료 시장 능력 확대
    • 세계 재생의료 시장에서의 인수합병(M&A) 및 합작투자(JV)

제7장 유력 기업 개요

  • Kite Pharma
  • Novartis
  • Vericel Corporation
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker Corporation
  • Spark Therapeutics
  • Zimmer Biomet Holdings, Inc.
LSH 24.05.02

Regenerative Medicine Market Trends and Forecast

The future of the global regenerative medicine market looks promising with opportunities in musculoskeletal disorders, wound care, oncology, ocular disorders, and diabetes. The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030, and it is forecast to grow at a CAGR of 3.0% from 2024 to 2030. The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

Emerging Trends in the Regenerative Medicine Market

Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.

A total of 94 figures / charts and 87 tables are provided in this more than 184-page report to help in your business decisions. Sample figures with some insights are shown below.

In this market, cell-based immunology & cell therapy is the largest product of regenerative medicine, whereas musculoskeletal disorders is the largest application. Growth in various segments of the regenerative medicine market are given below:

The study includes trends and forecast for the global regenerative medicine market by material, product, application, distribution channel, and region as follows:

By Material [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Synthetic
    • Scaffold
    • Artificial Vascular Graft Materials
    • Hydrogel Materials
  • Biologically Derived Materials
    • Collagen
    • Xenogeneic Materials
  • Genetically Engineered Materials
    • Deoxyribonucleic Acid Transfection Vectors
    • Genetically Manipulated Cells
    • Three-Dimensional Polymer Technology
    • Transgenics
    • Fibroblasts
    • Neural Stem Cells
    • Gene-Activated Matrices
  • Pharmaceuticals
    • Small Molecules
    • Biologics

By Product [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Cell-Based Immunotherapy & Cell Therapy Products
  • Tissue-Engineered Products
  • Small Molecules and Biologics
  • Gene Therapy Products

By Application [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Ocular Disorders
  • Diabetes
  • Other Applications

By Distribution Channel [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Hospitals
  • Clinics
  • Others

By Region [Value ($ Million) shipment analysis for 2018 - 2030]:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil

List of Regenerative Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies regenerative medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the regenerative medicine companies profiled in this report include.

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Regenerative Medicine Market Insights

  • Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.
  • Within this market, musculoskeletal disorders will remain the largest segment by application over the forecast period due to increasing orthopedic diseases and rising geriatric population.
  • North America will remain the largest region over the forecast period due to presence of advanced technologies and a large number of research institutes involved in the development of novel therapeutics.

Features of the Regenerative Medicine Market

  • Market Size Estimates: Regenerative medicine market size estimation in terms of value ($M).
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
  • Segmentation Analysis: Regenerative medicine market size by various segments, such as material, product, application, and distribution channel.
  • Regional Analysis: Regenerative medicine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different material, product, application, distribution channel, and regions for regenerative medicine market.
  • Strategic Analysis: This includes M&A and competitive landscape for the regenerative medicine .
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the regenerative medicine market size?

Answer:The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030.

Q2. What is the growth forecast for regenerative medicine market?

Answer:The regenerative medicine market is expected to grow at a CAGR of 3.0% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the regenerative medicine market?

Answer: The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

Q4. What are the major applications or end use industries for regenerative medicine?

Answer:Hospital and clinic are the major end uses for regenerative medicine

Q5. What are the emerging trends in regenerative medicine market?

Answer:Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.

Q6. Who are the key regenerative medicine companies?

Answer:Some of the key regenerative medicine companies are as follows:

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Q7.Which regenerative medicine raw material segment will be the largest in future?

Answer: Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.

Q8: In regenerative medicine market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region in next 5 years.

Q9. Do we receive customization in this report?

Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising potential, high-growth opportunities for the global regenerative medicine market by material (synthetic (scaffold, artificial vascular graft materials, and hydrogel materials), biologically derived materials (collagen and xenogeneic materials), genetically engineered materials (deoxyribonucleic acid transfection vectors, genetically manipulated cells, three-dimensional polymer technology, transgenics, fibroblasts, neural stem cells, and gene-activated matrices), and pharmaceuticals (small molecules and biologics)), product (cell-based immunotherapy & cell therapy products, tissue-engineered products, small molecules and biologics, and gene therapy products), application (musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications), distribution channel (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
  • Q. 2 Which segments will grow at a faster pace and why?
  • Q.3 Which region will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
  • Q.5 What are the business risks and threats to the market?
  • Q.6 What are the emerging trends in this market and the reasons behind them?
  • Q.7 What are some changing demands of customers in the market?
  • Q.8 What are the new developments in the market? Which companies are leading these developments?
  • Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in this market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M & A activities did take place in the last five years in this market?

Table of Contents

2. Market Background and Classifications

  • 2.1 Introduction, Background, and Classifications
  • 2.2 Supply Chain
  • 2.3 Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1 Macroeconomic Trends and Forecast
  • 3.2 Global Regenerative Medicine Market Trends and Forecast
  • 3.3 Global Regenerative Medicine Market by Material
    • 3.3.1 Synthetic
      • 3.3.1.1 Scaffold
      • 3.3.1.2 Artificial Vascular Graft Materials
      • 3.3.1.3 Hydrogel Materials
    • 3.3.2 Biologically Derived Materials
      • 3.3.2.1 Collagen
      • 3.3.2.2 Xenogeneic Materials
    • 3.3.3 Genetically Engineered Materials
      • 3.3.3.1 Deoxyribonucleic Acid Transfection Vectors
      • 3.3.3.2 Genetically Manipulated Cells
      • 3.3.3.3 Three-dimensional Polymer Technology
      • 3.3.3.4 Transgenics
      • 3.3.3.5 Fibroblasts
      • 3.3.3.6 Neural Stem Cells
      • 3.3.3.7 Gene-activated Matrices
    • 3.3.4 Pharmaceuticals
      • 3.3.4.1 Small Molecules
      • 3.3.4.2 Biologics
  • 3.4 Global Regenerative Medicine Market by Product
    • 3.4.1 Cell-Based Immunotherapy & Cell Therapy Products
    • 3.4.2 Tissue-Engineered Products
    • 3.4.3 Small Molecules And Biologics
    • 3.4.4 Gene Therapy Products
  • 3.5 Global Regenerative Medicine Market by Application
    • 3.5.1 Musculoskeletal Disorders
    • 3.5.2 Wound Care
    • 3.5.3 Oncology
    • 3.5.4 Ocular Disorders
    • 3.5.5 Diabetes
    • 3.5.6 Other Applications
  • 3.6 Global Regenerative Medicine Market by Distribution Channel
    • 3.6.1 Hospitals
    • 3.6.2 Clinic
    • 3.6.3 Others

4. Market Trends and Forecast Analysis by Region

  • 4.1 Global Regenerative Medicine Market by Region
  • 4.2 North American Regenerative Medicine Market
    • 4.2.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.2.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.2.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.2.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.2.5 The United States Regenerative Medicine Market
    • 4.2.6 The Canadian Regenerative Medicine Market
    • 4.2.7 The Mexican Regenerative Medicine Market
  • 4.3 European Regenerative Medicine Market
    • 4.3.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.3.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.3.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.3.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.3.5 The Regenerative Medicine Market of the United Kingdom
    • 4.3.6 The German Regenerative Medicine Market
    • 4.3.7 The French Regenerative Medicine Market
  • 4.4 APAC Regenerative Medicine Market
    • 4.4.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.4.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.4.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.4.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.4.5 The Chinese Regenerative Medicine Market
    • 4.4.6 The Indian Regenerative Medicine Market
    • 4.4.7 The Japanese Regenerative Medicine Market
  • 4.5 ROW Regenerative Medicine Market
    • 4.5.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.5.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.5.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.5.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.5.5 Brazilian Regenerative Medicine Market

5. Competitor Analysis

  • 5.1 Market Share Analysis
  • 5.2 Product Portfolio Analysis
  • 5.3 Operational Integration
  • 5.4 Geographical Reach
  • 5.5 Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1 Growth Opportunity Analysis
    • 6.1.1 Growth Opportunities for the Global Regenerative Medicine Market by Material
    • 6.1.2 Growth Opportunities for the Global Regenerative Medicine Market by Product
    • 6.1.3 Growth Opportunities for the Global Regenerative Medicine Market by Application
    • 6.1.4 Growth Opportunities for the Global Regenerative Medicine Market by Distribution Channel
    • 6.1.5 Growth Opportunities for the Global Regenerative Medicine Market by Region
  • 6.2 Emerging Trends in the Global Regenerative Medicine Market
  • 6.3 Strategic Analysis
    • 6.3.1 New Product Development
    • 6.3.2 Capacity Expansion of the Global Regenerative Medicine Market
    • 6.3.3 Mergers, Acquisitions, and Joint Ventures in the Global Regenerative Medicine Market

7. Company Profiles of Leading Players

  • 7.1 Kite Pharma
  • 7.2 Novartis
  • 7.3 Vericel Corporation
  • 7.4 Integra LifeSciences
  • 7.5 Wright Medical
  • 7.6 MiMedx
  • 7.7 Osiris Therapeutics
  • 7.8 Stryker Corporation
  • 7.9 Spark Therapeutics
  • 7.10 Zimmer Biomet Holdings, Inc.
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제